Stay updated on LUPUZOR Clinical Trial
Sign up to get notified when there's something new on the LUPUZOR Clinical Trial page.

Latest updates to the LUPUZOR Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about a Phase 3 study for IPP-201101 in patients with Systemic Lupus Erythematosus (SLE), while a new revision number has been added.SummaryDifference45%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
Stay in the know with updates to LUPUZOR Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LUPUZOR Clinical Trial page.